Track Laboratorios Farmaceuticos Rovi, S.A. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Laboratorios Farmaceuticos Rovi, S.A. ROVIN.MX · Stock Open Laboratorios Farmaceuticos Rovi, S.A. in new tab

1139.57 MXN
P/E
15.90
EPS
71.65
Yield
1.64%
P/B
4.22
ROE
28.65
Beta
0.23
Loading chart...
Key Metrics
P/E15.90
EPS71.65
Book Value270.04
Price to Book4.22
Debt/Equity15.02
% Insiders68.197%
Growth
Revenue Growth0.20%
Earnings Growth2.47%
Dividend
Dividend Yield1.64%
Annual dividends19.14 MXN
Ex-Div. DateJuly 14, 2026
Payout25.83%

DCF Valuation

Tweak assumptions to recompute fair value for Laboratorios Farmaceuticos Rovi, S.A. (ROVIN.MX)
Currency: MXN
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Laboratorios Farmaceuticos Rovi, S.A. Logo Laboratorios Farmaceuticos Rovi, S.A. Analysis (ROVIN.MX)

Spain Health Care Official Website Stock

Is Laboratorios Farmaceuticos Rovi, S.A. a good investment? Laboratorios Farmaceuticos Rovi, S.A. (ROVIN.MX) is currently trading at 1139.57 MXN.

In terms of valuation, the stock trades at a P/E ratio of 15.90. This valuation is generally in line with the broader market.

For income investors, Laboratorios Farmaceuticos Rovi, S.A. pays a dividend yield of 1.64%. With a payout ratio of 26%, the dividend appears sustainable.

Investor FAQ

Does Laboratorios Farmaceuticos Rovi, S.A. pay a dividend?

Yes, it pays an annual dividend of 19.14 MXN (1.64% yield).

What asset class is Laboratorios Farmaceuticos Rovi, S.A.?

Laboratorios Farmaceuticos Rovi, S.A. is classified as a Stock. You can compare it against 6 other assets in the "Related Symbols" list on this page.

Company Profile

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, sterile filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Further, it offers low-molecular-weight heparin, Okedi, and Rolcya; and develops Letrozole SIE and Risperidone QUAR. Its products are used for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Pozuelo de Alarcón, Spain. Laboratorios Farmaceúticos Rovi, S.A. operates as a subsidiary of Norbel Inversiones, S.L.

Exchange Ticker
MCE (Spain) ROVI.MC
PNK (United States) LABFF
MEX (Mexico) ROVIN.MX
STU (Germany) 41L.SG
FRA (Germany) 41L.F
LSE (United Kingdom) 0ILL.L
Trades
Dividend Yield
1.64%
Annual Dividends
19.14MXN
Next Ex. Div Date
July 14, 2026
Payout Ratio
25.83%
Dividend History paid per year (MXN)
Historical Dividends
Year Total Dividends
▸2027
29.80 MXN
July 5, 2027 (estimated) 29.7980
▸2026
18.96 MXN
July 14, 2026 18.9643
▸2025
18.48 MXN
July 15, 2025 18.4840
▸2024
21.82 MXN
July 9, 2024 21.8167
▸2023
25.57 MXN
July 3, 2023 25.5743
▸2022
18.89 MXN
July 5, 2022 18.8892
▸2021
7.54 MXN
July 5, 2021 7.5351
▸2020
3.46 MXN
Nov. 17, 2020 3.4612
Upcoming Dividends
Name Payment Date Status Amount
Laboratorios Farmaceuticos Rovi, S.A. Jul 14, 2026 18.964306 MXN
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion